Complement inhibition accelerates regeneration in a model of peripheral nerve injury

Molecular Immunology

Volumn 47, Issue 2-3, 2009, Pages 302-309

  Ramaglia, Valeria ^a   Tannemaat, Martijn Rudolf ^b   de Kok, Maryla ^a   Wolterman, Ruud ^a   Vigar, Miriam Ann ^c   King, Rosalind Helen Mary ^d   Morgan, Bryan Paul ^c   Baas, Frank ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Complement; Complement inhibitors; Crush injury; Recovery; Regeneration

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT DEFICIENCY; COMPLEMENT INHIBITION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; IMMUNOHISTOCHEMISTRY; MALE; MONITORING; MOTOR PERFORMANCE; NERVE CRUSH; NERVE FIBER REGENERATION; NERVE REGENERATION; NONHUMAN; PERIPHERAL NERVE INJURY; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RNA ISOLATION; SCIATIC NERVE; SENSORY NERVE CELL; SENSORY SYSTEM; SPINAL GANGLION; WILD TYPE;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT C6; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HEMOLYSIS; HUMANS; NERVE REGENERATION; PERIPHERAL NERVES; RATS; RECEPTORS, COMPLEMENT; RECOVERY OF FUNCTION;

ANIMALIA; RATTUS;

EID: 70450223893     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.09.019     Document Type: Article

References (33)

1. Baker R.S., Stava M.W., Nelson K.R., May P.J., Huffman M.D., and Porter J.D. Aberrant reinnervation of facial musculature in a subhuman primate: a correlative analysis of eyelid kinematics, muscle synkinesis, and motoneuron localization. Neurology 44 (1994) 2165-2173
2. Bhole D., and Stahl G.L. Molecular basis for complement component 6 (C6) deficiency in rats and mice. Immunobiology 209 (2004) 559-568
3. Bouldin T.W., Earnhardt T.S., and Goines N.D. Sequential changes in the permeability of the blood-nerve barrier over the course of ricin neuronopathy in the rat. Neurotoxicology 11 (1990) 23-34
4. de Jonge R.R., van Schaik I.N., Vreijling J.P., Troost D., and Baas F. Expression of complement components in the peripheral nervous system. Hum. Mol. Genet. 13 (2004) 295-302
5. De Koning P., Brakkee J.H., and Gispen W.H. Methods for producing a reproducible crush in the sciatic and tibial nerve of the rat and rapid and precise testing of return of sensory function. Beneficial effects of melanocortins. J. Neurol. Sci. 74 (1986) 237-246
6. Ferguson T.A., and Muir D. MMP-2 and MMP-9 increase the neurite-promoting potential of schwann cell basal laminae and are upregulated in degenerated nerve. Mol. Cell. Neurosci. 16 (2002) 157-167
7. Fujita T. Evolution of the lectin-complement pathway and its role in innate immunity. Nat. Rev. Immunol. 2 (2002) 346-353
8. Hare G.M., Evans P.J., Mackinnon S.E., Best T.J., Bain J.R., Szalai J.P., and Hunter D.A. Walking track analysis: a long-term assessment of peripheral nerve recovery. Plast. Reconstr. Surg. 89 (1992) 251-258
9. Harpel P.C., and Cooper N.R. Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin. J. Clin. Invest. 55 (1975) 593-604
10. Höke A. Mechanisms of Disease: what factors limit the success of peripheral nerve regeneration in humans?. Nat. Clin. Pract. Neurol. 2 (2006) 448-454
11. Hughes P.M., Wells G.M., Clements J.M., Gearing A.J., Redford E.J., Davies M., Smith K.J., Hughes R.A., Brown M.C., and Miller K.M. Matrix metalloproteinase expression during experimental autoimmune neuritis. Brain 121 (1998) 481-494
12. Hughes P.M., Wells G.M., Perry V.H., Brown M.C., and Miller K.M. Comparison of matrix metalloproteinase expression during Wallerian degeneration in the central and peripheral nervous systems. Neuroscience 113 (2002) 273-287
13. King R.H.M. Atlas of Peripheral Nerve Pathology (1999), Arnold, London
14. Misko A., Ferguson T., and Notterpek L. Matrix metalloproteinase mediated degradation of basement membrane proteins in Trembler J neuropathy nerves. J. Neurochem. 83 (2002) 885-894
15. Morgan B.P. Measurement of complement hemolytic activity, generation of complement-depleted sera, and production of hemolytic intermediates. Methods Mol. Biol. 150 (2000) 61-71
16. Mulligan M.S., Yeh C.G., Rudolph A.R., and Ward P.A. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury. J. Immunol. 148 (1992) 1479-1485
17. Nauta A.J., Roos A., and Daha M.R. A regulatory role for complement in innate immunity and autoimmunity. Int. Arch. Allergy Immunol. 134 (2004) 310-323
18. Nguyen Q.T., Sanes J.R., and Lichtman J.W. Pre-existing pathways promote precise projection patterns. Nat. Neurosci. 5 (2002) 861-867
19. Piddlesden S.J., Storch M.K., Hibbs M., Freeman A.M., Lassmann H., and Morgan B.P. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J. Immunol. 152 (1994) 5477-5484
20. Ramaglia V., King R.H., Nourallah M., Wolterman R., de Jonge R., Ramkema M., Vigar M.A., van der Wetering S., Morgan B.P., Troost D., and Baas F. The membrane attack complex of the complement system is essential for rapid Wallerian degeneration. J. Neurosci. 27 (2007) 7663-7672
21. Ramaglia V., Daha M.R., and Baas F. The complement system in the peripheral nerve: friend or foe?. Mol. Immunol. 45 (2008) 3865-3877
22. Ramaglia V., Wolterman R., de Kok M., Vigar M.A., Wagenaar-Bos I., King R.H., Morgan B.P., and Baas F. Soluble complement receptor 1 protects the peripheral nerve from early axon loss after injury. Am. J. Pathol. 172 (2008) 1043-1052
23. Ramaglia V., King R.H., Morgan B.P., and Baas F. Deficiency of the complement regulator CD59a exacerbates Wallerian degeneration. Mol. Immunol. 46 (2009) 1892-1896
24. Romanic A.M., and Madri J.A. Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol. 4 (1994) 145-156
25. Schafer M., Fruttiger M., Montag D., Schachner M., and Martini R. Disruption of the gene for the myelin-associated glycoprotein improves axonal regrowth along myelin in C57BL/Wlds mice. Neuron 16 (1996) 1107-1113
26. Schlaepfer W.W., and Bunge R.P. Effects of calcium ion concentration on the degeneration of amputated axons in tissue culture. J. Cell. Biol. 59 (1973) 456-470
27. Sharshar T., Durand M.C., Lefaucheur J.P., Lofaso F., Raphaël J.C., Gherardi R.K., and Créange A. MMP-9 correlates with electrophysiologic abnormalities in Guillain-Barré syndrome. Neurology 59 (2002) 1649-1651
28. Soufan A.T., Ruijter J.M., van den Hoff M.J., de Boer P.A., Hagoort J., and Moorman A.F. Three-dimensional reconstruction of gene expression patterns during cardiac development. Physiol. Genomics 13 (2003) 187-195
29. Tessier-Lavigne M., and Goodman C.S. The molecular biology of axon guidance. Science 274 (1996) 1123-1133
30. Thomas P.K. Changes in the endoneurial sheaths of peripheral myelinated nerve fibres during Wallerian degeneration. J. Anat. 98 (1964) 175-182
31. Tomita K., Kubo T., Matsuda K., Yano K., Tohyama M., and Hosokawa K. Myelin-associated glycoprotein reduces axonal branching and enhances functional recovery after sciatic nerve transection in rats. Glia 55 (2007) 1498-1507
32. Van der Zee, C.E., Kreft, M., Beckers, G., Kuipers, A., Sonnenberg, A., 2008. Conditional deletion of the Itgb4 integrin gene in Schwann cells leads to delayed peripheral nerve regeneration. J. Neurosci. 28, 11292-11303.
33. Weisman H.F., Bartow T., Leppo M.K., Boyle M.P., Marsh, Carson G.R., Roux K.H., Weisfeldt M.L., and Fearon D.T. Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardium. Trans. Assoc. Am. Physicians 103 (1990) 64-72